Key Takeaways
- • Ivory, a Mumbai-based brain health startup, has raised $1 million in seed funding led by Draper Associates, with participation from SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI to strengthen its cognitive assessment platform.
- • The startup will deploy capital to enhance its technology stack, expand clinical capabilities, and build scalable, evidence-based solutions for early cognitive screening and proactive brain health management.
- • Founded in early 2023 by Issac John and Rahul Krishnan, Ivory combines neuroscience, neuropsychology, and data-driven interventions to address a critical gap in India's healthcare ecosystem by making cognitive screening accessible as part of routine preventive care.
- • Ivory has secured multiple funding tranches, including a $1 million co-led round with IIM-A Ventures and Capital-A in April 2025 and a $500,000 investment from Capital-A in February 2024, demonstrating investor confidence in the cognitive health sector.
- • The platform recently expanded partnerships with established healthcare providers, including a collaboration with Metropolis Healthcare to launch the TruHealth Mind & Body package, combining pathology diagnostics with neuroscience-based cognitive assessments.
Summary
Ivory, a Mumbai-based brain health startup, has secured $1 million in seed funding to accelerate development of its AI-based cognitive assessment platform and expand clinical capabilities. The funding round was led by Draper Associates and includes participation from SAGE Venture Fund, MoSJE, IFCI Ventures, and SIDBI. Co-founded in early 2023 by Issac John and Rahul Krishnan, Ivory focuses on early detection and proactive cognitive care through clinical-grade assessments and personalized brain health solutions delivered via mobile application.
The fresh capital will be allocated toward strengthening Ivory's technology infrastructure, expanding its multidisciplinary clinical team (spanning neuroscience, neurology, general medicine, and neuropsychology), and developing scalable, evidence-based solutions for cognitive health management. The startup addresses a significant gap in India's healthcare system by making cognitive screening accessible, trackable, and integrated into routine preventive care—a market segment with limited penetration across the Indian medical infrastructure.
Ivory's growth trajectory reflects sustained investor interest in the cognitive health space. The startup has raised multiple funding tranches over the past two years: a $1 million co-led round with IIM-A Ventures and Capital-A in April 2025, followed by a $500,000 investment from Capital-A in February 2024. The company gained additional visibility as a featured participant on Shark Tank India, enhancing brand recognition within the Indian startup ecosystem.
Beyond capital raise, Ivory has accelerated partnership expansion across established healthcare providers. The startup recently collaborated with Metropolis Healthcare—a leading diagnostic and pathology services provider—to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments. This partnership signals ecosystem maturation and indicates growing acceptance of cognitive screening as a standard preventive health service in India.
The fresh capital will be allocated toward strengthening Ivory's technology infrastructure, expanding its multidisciplinary clinical team (spanning neuroscience, neurology, general medicine, and neuropsychology), and developing scalable, evidence-based solutions for cognitive health management. The startup addresses a significant gap in India's healthcare system by making cognitive screening accessible, trackable, and integrated into routine preventive care—a market segment with limited penetration across the Indian medical infrastructure.
Ivory's growth trajectory reflects sustained investor interest in the cognitive health space. The startup has raised multiple funding tranches over the past two years: a $1 million co-led round with IIM-A Ventures and Capital-A in April 2025, followed by a $500,000 investment from Capital-A in February 2024. The company gained additional visibility as a featured participant on Shark Tank India, enhancing brand recognition within the Indian startup ecosystem.
Beyond capital raise, Ivory has accelerated partnership expansion across established healthcare providers. The startup recently collaborated with Metropolis Healthcare—a leading diagnostic and pathology services provider—to launch the TruHealth Mind & Body package, an integrated preventive health offering that combines pathology diagnostics with neuroscience-based cognitive assessments. This partnership signals ecosystem maturation and indicates growing acceptance of cognitive screening as a standard preventive health service in India.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.